BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17066095)

  • 21. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
    Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of infant leukemias: challenge and promise.
    Brown P
    Hematology Am Soc Hematol Educ Program; 2013; 2013():596-600. PubMed ID: 24319237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug discovery in rare indications: opportunities and challenges.
    Richon VM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():19-23. PubMed ID: 24319157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and perspective of current Brazilian studies on the epidemiology of childhood leukemia.
    Pombo de Oliveira MS; Koifman S; Vasconcelos GM; Emerenciano M; de Oliveira Novaes C;
    Blood Cells Mol Dis; 2009; 42(2):121-5. PubMed ID: 19064327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity.
    Inukai T; Zhang X; Goto M; Hirose K; Uno K; Akahane K; Nemoto A; Goi K; Sato H; Takahashi K; Honna H; Kagami K; Nakamoto K; Yagita H; Okumura K; Koyama-Okazaki T; Nakazawa S; Sugita K
    Leukemia; 2006 Dec; 20(12):2119-29. PubMed ID: 17066095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting epigenetic programs in MLL-rearranged leukemias.
    Bernt KM; Armstrong SA
    Hematology Am Soc Hematol Educ Program; 2011; 2011():354-60. PubMed ID: 22160057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In focus: MLL-rearranged leukemia.
    de Boer J; Walf-Vorderwülbecke V; Williams O
    Leukemia; 2013 Jun; 27(6):1224-8. PubMed ID: 23515098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia.
    Saraei R; Soleimani M; Movassaghpour Akbari AA; Farshdousti Hagh M; Hassanzadeh A; Solali S
    Biomed Pharmacother; 2018 Nov; 107():1010-1019. PubMed ID: 30257312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement.
    Bueno C; Montes R; Catalina P; Rodríguez R; Menendez P
    Leukemia; 2011 Mar; 25(3):400-10. PubMed ID: 21135858
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.